Circulating Bacterial DNA: A New Paradigm for Cancer Diagnostics
Cell-free DNA applications for screening, diagnosis and treatment monitoring are increasingly being developed for a range of different cancers. While most of these applications investigate circulating tumor DNA (ctDNA) or methylation profiles of ctDNA, circulating bacterial DNA (cbDNA) has also been...
Main Authors: | Tamara Glyn, Rachel Purcell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.831096/full |
Similar Items
-
Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
by: Preawwalee Wintachai, et al.
Published: (2021-05-01) -
Circulating cell-free DNA and its clinical utility in cancer
by: Salviano-Silva Amanda, et al.
Published: (2022-08-01) -
The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study
by: Qi Zeng, et al.
Published: (2021-03-01) -
Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
by: Miles W. Grunvald, et al.
Published: (2020-10-01) -
Remote immune processes revealed by immune-derived circulating cell-free DNA
by: Ilana Fox-Fisher, et al.
Published: (2021-11-01)